CLB Core Laboratories N V

Price (delayed)

$16.645

Market cap

$779.93M

P/E Ratio

21.07

Dividend/share

$0.04

EPS

$0.79

Enterprise value

$980.19M

Core Laboratories N.V. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70 ...

Highlights
The stock's price to earnings (P/E) is 29% less than its last 4 quarters average of 30.1
CLB's equity is up by 22% YoY
CLB's net income has soared by 89% year-on-year but it is down by 11% since the previous quarter
Core Laboratories N V's EPS has soared by 88% YoY but it has decreased by 10% from the previous quarter

Key stats

What are the main financial stats of CLB
Market
Shares outstanding
46.86M
Market cap
$779.93M
Enterprise value
$980.19M
Valuations
Price to book (P/B)
3.46
Price to sales (P/S)
1.52
EV/EBIT
18.05
EV/EBITDA
13.99
EV/Sales
1.92
Earnings
Revenue
$509.79M
EBIT
$54.29M
EBITDA
$70.07M
Free cash flow
$14.76M
Per share
EPS
$0.79
Free cash flow per share
$0.32
Book value per share
$4.81
Revenue per share
$10.92
TBVPS
$10.28
Balance sheet
Total assets
$586.4M
Total liabilities
$356.59M
Debt
$215.39M
Equity
$224.82M
Working capital
$135.04M
Liquidity
Debt to equity
0.96
Current ratio
2.53
Quick ratio
1.41
Net debt/EBITDA
2.86
Margins
EBITDA margin
13.7%
Gross margin
21.5%
Net margin
7.2%
Operating margin
10.7%
Efficiency
Return on assets
6.2%
Return on equity
17.1%
Return on invested capital
9%
Return on capital employed
10.9%
Return on sales
10.6%
Dividend
Dividend yield
0.24%
DPS
$0.04
Payout ratio
5.1%

CLB stock price

How has the Core Laboratories N V stock price performed over time
Intraday
-2.03%
1 week
-0.27%
1 month
0.03%
1 year
-24.34%
YTD
-5.75%
QTD
-2.55%

Financial performance

How have Core Laboratories N V's revenue and profit performed over time
Revenue
$509.79M
Gross profit
$109.83M
Operating income
$54.64M
Net income
$36.68M
Gross margin
21.5%
Net margin
7.2%
CLB's net income has soared by 89% year-on-year but it is down by 11% since the previous quarter
CLB's net margin has soared by 80% YoY but it is down by 11% from the previous quarter
Core Laboratories N V's operating income has increased by 32% YoY
The operating margin has increased by 26% YoY

Growth

What is Core Laboratories N V's growth rate over time

Valuation

What is Core Laboratories N V stock price valuation
P/E
21.07
P/B
3.46
P/S
1.52
EV/EBIT
18.05
EV/EBITDA
13.99
EV/Sales
1.92
Core Laboratories N V's EPS has soared by 88% YoY but it has decreased by 10% from the previous quarter
The stock's price to earnings (P/E) is 29% less than its last 4 quarters average of 30.1
The P/B is 57% below the 5-year quarterly average of 8.3 and 25% below the last 4 quarters average of 4.7
CLB's equity is up by 22% YoY
CLB's price to sales (P/S) is 32% lower than its 5-year quarterly average of 2.3 and 22% lower than its last 4 quarters average of 2.0
The company's revenue rose by 4.1% YoY

Efficiency

How efficient is Core Laboratories N V business performance
The ROA has soared by 82% YoY but it has contracted by 11% from the previous quarter
The return on equity has surged by 53% year-on-year but it has declined by 15% since the previous quarter
The return on invested capital is up by 30% year-on-year but it has declined by 2.2% since the previous quarter
Core Laboratories N V's ROS has increased by 26% YoY but it has decreased by 2.8% from the previous quarter

Dividends

What is CLB's dividend history
DPS
$0.04
Dividend yield
0.24%
Payout ratio
5.1%
Recent dividends

Financial health

How did Core Laboratories N V financials performed over time
The total assets is 64% greater than the total liabilities
CLB's current ratio is up by 23% year-on-year but it is down by 7% since the previous quarter
The quick ratio has increased by 18% YoY
CLB's debt is 4.2% less than its equity
CLB's equity is up by 22% YoY
The debt to equity has decreased by 21% YoY and by 6% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.